Financial Ratios

TRANSGENE BIOTEK LTD.

NSE : NABSE : 526139ISIN CODE : INE773D01018Industry : Hospital & Healthcare ServicesHouse : Private
BSE7.47-0.2 (-2.61 %)
PREV CLOSE ( ) 7.67
OPEN PRICE ( ) 7.52
BID PRICE (QTY) 7.29 (1250)
OFFER PRICE (QTY) 7.47 (10721)
VOLUME 90840
TODAY'S LOW / HIGH ( )7.29 7.95
52 WK LOW / HIGH ( ) 2.3612.46
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.79-1.37-1.38-1.45-1.16
   CEPS(Rs)-0.14-0.06-0.07-0.140.15
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-0.82-0.030.621.993.44
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-1107.61-531.84-307.220.00-944.20
   EBIT Margin(%)-9775.530.00-5993.540.000.00
   Pre Tax Margin(%)0.000.00-6153.440.000.00
   PAT Margin (%)0.000.00-6153.440.000.00
   Cash Profit Margin (%)-1921.19-550.95-309.700.001545.27
Performance Ratios
   ROA(%)-17.24-24.70-20.09-17.75-12.27
   ROE(%)0.00-465.75-105.59-53.27-28.87
   ROCE(%)-57.49-73.15-49.07-34.91-21.35
   Asset Turnover(x)0.000.000.000.00
   Sales/Fixed Asset(x)0.000.000.000.00
   Working Capital/Sales(x)-0.01-0.01-0.010.00-0.01
Efficiency Ratios
   Fixed Capital/Sales(x)1953.461241.19634.570.001508.91
   Receivable days0.000.000.000.000.00
   Inventory Days425.34242.3663.443548.64187.35
   Payable days1187.32-1746.921857.708270.204527.45
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-17.83-57.27-66.09-21.4127.51
   Price/Book(x)-3.04-138.837.441.511.16
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)580.62453.93271.429256.18551.86
   EV/Core EBITDA(x)-73.57-158.33-181.18-48.3528.83
   EV/EBIT(x)-5.94-3.87-4.53-3.13-4.61
   EV/CE(x)0.981.060.980.580.59
   M Cap / Sales342.50315.51204.686378.80425.15
Growth Ratio
   Net Sales Growth(%)-36.46-48.874642.12-94.98-39.71
   Core EBITDA Growth(%)-74.912.1462.89-150.16-74.10
   EBIT Growth(%)47.07-0.113.96-24.05-84.52
   PAT Growth(%)42.240.304.83-24.67-36.56
   EPS Growth(%)42.230.304.83-24.67-36.56
Financial Stability Ratios
   Total Debt/Equity(x)-2.11-60.992.430.680.35
   Current Ratio(x)0.090.080.050.050.05
   Quick Ratio(x)0.080.070.040.050.05
   Interest Cover(x)-8.64-44.40-37.48-27.78-32.42
   Total Debt/Mcap(x)0.700.440.330.450.30

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.